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Polyomavirus (PyV) infection induces protective T cell-independent (TI) IgM and IgG antibody responses in T cell-deficient mice, but these
responses are not generated by immunization with viral proteins or virus like particles. We hypothesized that innate signals contribute to the
generation of isotype-switched antiviral antibody responses. We studied the role of complement receptor (CR2) engagement in TI and T cell-
dependent (TD) antibody responses to PyV using CR2-deficient mice. Antiviral IgG responses were reduced by 80–40% in CR2−/− mice
compared to wild type. Adoptive transfer experiments demonstrated the need for CR2 not only in TD, but also in TI IgG responses to PyV.
Transfer of CR2−/− B lymphocytes to SCID mice resulted in TI antiviral IgG responses that corresponded to 10% of that seen in wild-type B cell-
reconstituted mice. Thus, our studies revealed a profound dependence of TI and TD antiviral antibody responses on CR2-mediated signals in PyV-
infected mice, where the viral antigen is abundant and persistent.
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tive pathways is an important step in the innate immune
responses to pathogens, including viruses. Covalent attachment
of C3 fragments to virus particles may indicate the infectious
origin of the antigen and may lead to enhanced efficiency of B
cell responses via co-ligation of the B cell receptor (BCR) and
the complement receptor signaling complex CD21/CD19/CD81
on B lymphocytes (Carroll, 2004).
The role of the binding of active complement components
(e.g., C3) to the complement receptors CD35 and CD21 in
antibody responses to TD protein antigens is well documented.
The two complement receptors CD35 and CD21 are differen-
tially spliced products encoded by the Cr2 gene in mice, and
they both are expressed on B lymphocytes and on follicular
dendritic cells (FDC). CD35/CD21 (CR2) signaling on B cells
decreases the activation threshold of the BCR, thus enhancing
TD B cell responses to limiting amounts of antigens (Carter and⁎ Corresponding author. Fax: +1 508 856 5870.
E-mail address: Eva.Szomolanyi-Tsuda@umassmed.edu
(E. Szomolanyi-Tsuda).
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doi:10.1016/j.virol.2006.04.018Fearon, 1992; Dempsey et al., 1996). In addition, CR2 signaling
on B cells promotes B cell survival in TD responses, probably
by enhancing B cell survival in the germinal centers (Fischer et
al., 1998). Finally, CR2 expression on FDCs is thought to
promote secondary and memory B cell responses by prolonging
antigen persistence (Chen et al., 2000; Wu et al., 2000).
The effect of complement receptor signaling on antibody
responses to TI antigens is less clear. Early studies done by
Pepys et al. with animals treated with complement-depleting
cobra venom factor (CVF) suggested that complement is not
necessary for the induction of TI antibody responses to the
synthetic antigen polyvinylpyrrolidone (Pepys, 1974; Pepys,
1972). Subsequently, however, other studies demonstrated
impaired antibody responses in C3-deficient dogs, and in
CVF-treated mice immunized with low dose of the TI antigens
DNP-Ficoll and DNP-polyacrylamide (Matsuda et al., 1978;
O'Neil et al., 1988). Treatment of mice with a monoclonal
antibody directed against the C3d-binding site of CR2 also led
to greatly reduced antibody responses in nude mice and
decreased antibody responses in normal mice to the type 2 TI
antigen dextran (Wiersma et al., 1991), suggesting that CR2
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CR2 dependence of TI responses to polysaccharide bacterial
cell wall components (prototypical TI type 2 antigens) was
recently re-examined in Cr2−/− mice. Decreased primary IgM
and IgG responses to group B Streptococcal polysaccharides
were found in the absence of CR2 expression, and this effect
was thought to be related to impaired localization of this antigen
to the marginal zone and to FDC in the spleen (Pozdnyakova et
al., 2003). Marginal zone (MZ) B cells, which express CD21 at
a higher level than follicular B cells, are believed to play a major
role in IgM and IgG3 antibody secretion to TI type 2 antigens.
This idea is supported by observations in both men and mice.Fig. 1. Virus-specific antibody responses of PyV-infected wild-type and CR2 KO mi
and CR2 KO mice on day 7 post-infection, expressed in arbitrary U/ml. Six mice per
day 21 (P = 0.03), (D) on day 28 (P = 0.02), and (E) on day 33, 5 days after re-infe
significant differences between the groups, the error bars show standard deviations.The onset of B cell responsiveness to bacterial polysaccharides
and the maturation of MZ B cells coincides in childhood, and in
irradiated mice the reconstitution of MZ B cells is associated
with the reappearance of antibody responses to TI type 2
antigens (Lane et al., 1986; Lee et al., 1991).
Do CR2-mediated mechanisms operate to enhance antiviral
antibody responses in vivo? Although several viral models have
been studied, the role of CR2 signaling in antiviral antibody
responses in general is still not well understood. In many virus
infections, the amount of antigen is not limiting, and thus
antiviral TD antibody responses would not be expected to
depend on CR2 signaling. Consistent with this idea, somece. (A) VP1-specific IgM concentrations in serum samples taken from wild-type
group were tested. (B) VP1-specific IgG responses on day 14 (P < 0.02), (C) on
ction on day 28 (P = 0.025); n = 6 per group. The asterisks indicate statistically
The experiment shown is a representative of three similar experiments.
Fig. 2. IgG isotypes of VP1-specific serum antibodies of wild-type and Cr2−/−
mice. The isotype-specific ELISA assays were done on serum samples obtained
on day 21 following PyV infection. The IgG1, IgG2a, IgG2b, and IgG3
concentrations are expressed in arbitrary units. The differences in IgG2a, IgG2b,
and IgG3 are statistically significant (P = 0.017, P = 0.02, and P = 0.0004 for
IgG2a, IgG2b, and IgG3, respectively); n = 5–6 per group.
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with live, replicating viruses, such as LCMVand VSV, were not
affected by a deficiency in C3 or CR2, whereas antibody
responses to non-replicating forms (mutant or killed) of these
viruses were C3 and CR2 dependent (Ochsenbein et al., 1999).
Induction of IgG responses by the HSV strain KOS1.1 that can
replicate at the periphery, however, was greatly reduced in the
absence of CR2 (Da Costa et al., 1999). Antigen persists in
many virus infections, and in these situations the CR2 on FDCs
may not be essential for the maintenance of memory B cells or
long-living plasma cells. In VSV infection in mice, neutralizing
serum IgG levels several months post-infection are normal in
C3-deficient mice, slightly reduced in C4- and CR2-deficient
mice, and greatly reduced in CD19 KO mice compared to wild
type. These changes in serum IgG levels are accompanied with
similar decreases in antibody forming cell frequencies in the
bone marrow (Ochsenbein et al., 1999), suggesting a role for
CR2 in the maintenance of long-term humoral immune
responses in this virus infection.
Effects of C3 on TI antibody responses to viruses have also
been observed. Ochsenbein et al. (1999) reported that TI
neutralizing IgM responses to VSV, polio virus, and to
recombinant vaccinia virus carrying VSV G protein were
delayed and decreased in C3− mice, whereas the TD IgGFig. 3. ASC numbers in the spleen (A) and in the bone marrow (B) of wild-type a
significant differences between the groups, the error bars show standard deviation, 3responses of the C3−mice to these viruses seemed to be normal
(Ochsenbein et al., 1999).
The goal of the studies described here is to better understand
how TI and TD IgM and IgG responses are affected by CR2
signaling in infections with rapidly replicating viruses, using
PyV infection in mice as a unique model of TI and TD antiviral
antibody responses. PyV, although can be presented in the form
of peptide antigens on MHC classes I and II, thus it is able to
activate T cells, can also elicit biologically significant,
protective, isotype-switched TI antibody responses in the
absence of functional T cells in the host (Szomolanyi-Tsuda et
al., 1998). The TI IgG responses are directed against the VP1
capsid protein, and they are generated only by live virus
infection, not by immunization by virus-like particles. We have
postulated a role for innate immune signals activated by the
virus in the induction of these VP1-specific IgG responses. This
report demonstrates that CR2 has a significant role in enhancing
both TD and TI antiviral IgG responses in mice infected with
PyV, despite the abundance and persistence of the virus antigen.
Thus, CR2-mediated signals activated during infection with
PyV in T cell-deficient hosts may be important innate helper
signals enhancing humoral immunity.
Results
Reduced antiviral IgG responses in PyV-infected CR2 KO mice
To test the effect of CR2 expression on humoral immune
responses to PyV, we compared virus-specific IgM and IgG
levels in the serum of Cr2−/− mice and normal mice at
different time points following PyV infection, using polyoma
major capsid protein (VP1)-specific ELISA assays. IgM titers,
which peak on days 5–7, were not significantly different
between the two groups on day 7 (Fig. 1A) or on day
20 (data not shown). VP1-specific IgG levels of serum
samples taken on day 14, however, were significantly reduced
in Cr2−/− mice compared to their wild-type counterparts. In
the representative experiment shown in Fig. 1B, this
reduction was more than 2-fold (below 50% of the IgG
titers of wild type), and the antiviral IgG titers, although
continued to increase with time in both groups, remainednd CR2 KO mice on day 20 post-infection. The asterisk indicates statistically
–4 mice per group were tested.
Fig. 4. Viral load in organs of wild-type and CR2-deficient mice on day 28 post-
infection, expressed as viral copy number/1000 cells, determined by real-time
PCR. Four mice per group were tested.
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time points tested (days 21 and 28) (Figs. 1C and D). Re-
infection with PyV on day 28 led to the doubling of VP1-
specific IgG titers by day 33 (5 days post-re-infection) in
both wild-type and Cr2−/− mice. This experiment demon-
strated that although the significant differences in the antiviral
IgG levels were maintained in the two groups of mice after
repeated infections, Cr2−/− mice could also give good
responses to PyV re-infection (Fig. 1E).
We then determined whether the reduction in virus-specific
IgG titers in CR2-deficient mice reflected impaired switching to
a particular IgG isotype. Isotype-specific ELISA assays showed
that there was a reduction in all virus-induced isotypes testedFig. 5. VP1-specific IgG titers in serum samples of SCID mice reconstituted with s
(P = 0.003), (C) day 28 (P = 0.018), and (D) day 33 (P = 0.007), 5 days following re-
standard deviations. The experiment is a representative of three similar experiments(IgG1, IgG2a, IgG2b, and IgG3; Fig. 2), suggesting that the
diminished VP1-specific IgG responses did not arise as a
consequence of the impairment of switching per se to a specific
isotype, rather they may result from defects in survival and/or
differentiation of the IgG-secreting B cells.
The virus-specific antibody-secreting cells (ASC or plasma
cells) are mostly in the spleen during acute systemic virus
infection, but after the resolution of the acute infection a large
number of the ASCs migrate to the bone marrow. The plasma
cells residing in the bone marrow are thought to be long lived,
and together with the memory B cells they are responsible for
the maintenance of long-term humoral immune responses
(Slifka et al., 1998). VP1-specific ASC numbers in the spleen
and bone marrow tested by ELISPOT assays on day 20 post-
infection were lower in CR2 KO mice than in their wild-type
counterparts (Fig. 3). As the decrease was ∼50% at both of
these locations, the diminished antibody responses in the CR2
KO mice are probably not due to a specific defect in the
formation of the bone marrow-residing plasma cells.
Differences in virus clearance in Cr2−/− and wild-type mice
To assess the importance of CR2-mediated mechanisms in
the clearance of PyV infection in the host, we determined the
viral load in the spleens and kidneys of Cr2−/− and wild-type
mice using real-time PCR. DNA samples were prepared from
these organs harvested at 4 weeks post-infection and were
analyzed using PyV sequence-specific primers to determine the
number of the PyV genome copies in the sample, then thesepleen cells of Cr2−/− and wild-type mice. (A) Day 14 (P = 0.02), (B) day 21
infection with PyV. Asterisks indicate statistical significance, the error bars show
; n = 4 per group.
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(determined by mouse β actin-specific primers). The kidneys of
CR2 KO mice had 40–700 copies of PyV DNA per 103 cells,
whereas the viral DNA was very low but detectable in the
samples from wild-type kidneys on day 28 post-infection (Fig.
4) (the limit of detection is approximately one copy of PyV
genome per 103 cells). Kidneys are well-known sites of
persistence in PyV-infected mice (Rochford et al., 1992).
Remarkably, viral DNA levels in the spleens of all of the CR2
KO mice were below the limit of detection of our assays,
although PyV was readily detectable in wild-type spleens (Fig.
4). These differences in virus clearance in the CR2 KO mice
compared to wild-type in the kidneys may be the consequences
of the lower antiviral IgG levels, or lack of other complement-
dependent mechanisms involved in the control of the virus. In
the spleens, the lack of CR2 on the FDCs may decrease the level
of the persistence of virus–antibody complexes.
TD IgG responses rapidly decline in SCID mice reconstituted
with Cr2−/− B cells
The magnitude and longevity of T cell-dependent antibody
responses that were generated by Cr2−/− B cells in the absence
of a newly emerging B cell population from the bone marrow
was tested by performing adoptive transfer experiments. Spleen
cells from naive Cr2−/−mice as well as from wild-type controls
were transferred into SCID mice and then tested for their ability
to secrete IgM and IgG in response to PyV. Similar to the
responses of PyV-infected Cr2−/− mice described above, thereFig. 6. VP1-specific IgM and IgG titers in serum samples of SCID mice reconstituted
responses (P = 0.077), (B) day 21 serum IgG (P < 0.04), and (C) day 28 IgG (
representative of three similar experiments; n = 6 per group. (D) VP1-specific serum I
(open circles) mice on day 16 post-infection. Three to four mice per group were teswere no appreciable differences in early (day 5) IgM levels in
mice reconstituted with Cr2−/− or normal spleen cell popula-
tions (data not shown). IgG levels tested on day 14, however,
were significantly decreased in mice that carried Cr2−/− B cells
(Fig. 5A), corresponding to approximately 20% of the
responses in mice reconstituted with wild-type splenocytes
(P = 0.02). Moreover, unlike in the Cr2−/− mice, these IgG
responses decreased to undetectable levels by days 21–28 (Figs.
5B–C), suggesting that the transferred B cells, which were
activated by PyV and differentiated into IgG-secreting plasma
cells, were short-lived. Indeed, an increased percentage of GC
phenotype B cells (CD43−/B220+/CD19+/Gl7+) isolated from
the spleens of PyV-infected CR2-deficient mice stained positive
with annexin V (74% on day 3 and 73–75% on day 14), an early
marker of apoptotic cells death, compared to GC B cells from
PyV-infected wild-type mice (59–64% on day 3 and 59–68%
on day 14, respectively).
TI responses to PyV are impaired in the absence of CR2
PyV is an effective inducer of TI IgG responses in T cell-
deficient mice. The antibodies generated in the absence of T cell
help have neutralizing activity and are able to clear the virus
partially (Szomolanyi-Tsuda and Welsh, 1996, and EST
unpublished results), thus protecting T cell-deficient mice
from the acute, lethal effect of PyV infection observed in
SCID mice (Szomolanyi-Tsuda et al., 1994). A major goal of
these studies with CR2-deficient mice was to determine whether
TI IgG responses are enhanced by CR2 signaling in PyV-with T cell-depleted spleen cells of Cr2−/− and wild-type mice. (A) Day 5 IgM
P = 0.01). The asterisks indicate statistical significance. The experiment is a
gG of PyV-infected, CD4 T cell-depleted CR2 KO (closed circles) and wild-type
ted, P = 0.058 for 1:100 dilution.
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depleted spleen cells from uninfected Cr2−/− mice or wild-type
mice into SCID mouse recipients, and following PyV infection
we evaluated antiviral IgM and IgG responses of the
reconstituted mice. Although IgM levels on day 5 post-infection
of the mice with CR2-deficient B cells were on average lower
than those of their wild-type counterparts, these differences
were not statistically significant (Fig. 6A). Days 21 and 28 IgG
responses of the mice with T cell-depleted CR2 KO splenocytes
were significantly diminished, on day 21 approximately 20%
(P < 0.04), and on day 28 about 13% (P = 0.01) compared to
wild-type (Figs. 6B and C). CR2 KO mice depleted in vivo of
CD4 T cells by treatment with GK1.5 monoclonal antibody also
showed decreased IgG responses to PyV compared to CD4-
depleted wild-type mice in day 16 post-infection (Fig. 6D),
suggesting that the lack of CR2 has an influence on TI antibody
responses. It is important to consider, however, that the CD4-
depleted mice had CD8 T cells that could effectively reduce
viral antigen levels (Byers et al., 2003), and CD4-negative T
cells might have also affected B cell responses (Sha and
Compans, 2000); whereas using SCID mice reconstituted with
T cell-depleted spleen cells, we studied B cell responses without
the influence of any T cell. Our conclusion from these
experiments taken together is that for normal TI IgG responses
CR2 seem to be required, supporting the hypothesis that innate
immune-derived signals are involved in the generation of these
responses.
Discussion
We found that both TI and TD IgG responses to PyV are
impaired in mice deficient in CR2 expression. Previously, it was
demonstrated with inert protein antigens that at low antigen
doses TD antibody responses depend largely on CR2 signaling
(Ahearn et al., 1996; Heyman et al., 1990; Molina et al., 1996;
Ochsenbein et al., 1999). For example, linkage of 2–3 copies of
C3d to hen egg lysozyme, a TD antigen, enhanced the
immunogenicity of this antigen 103- to 104-fold (Dempsey et
al., 1996). Complement proteins are important players of the
innate immune system, and the activation of the complement
cascade is initiated by many pathogens, including viruses
(Cooper et al., 1976). As a result of complement activation, C3d
complement fragments are covalently attached to the antigen,
perhaps “marking” its infectious origin. This modification may
serve to enhance the ability of viral antigens, particularly when
present at low amounts, to generate vigorous humoral immune
responses, demonstrating the collaboration of innate and
adaptive immunity to orchestrate the fight against invading
pathogens. Reports showing the CR2 dependence of IgG
responses when mice are immunized with non-replicating
(inactivated or mutant) viruses, or viruses with limited
replicative potential in the periphery, but not in live systemic
virus infections support this hypothesis (Da Costa et al., 1999;
Ochsenbein et al., 1999). PyV, however, replicates rapidly and
extensively in mice. Thus, our findings suggest that CR2 may
have a positive effect on TD responses even when the antigen is
not limiting but abundant.The antiviral IgG responses in CR2-deficient mice were only
slightly reduced compared to the responses in wild type, and the
difference was the same from day 14 and thereafter (Fig. 1). In
adoptive transfer experiments, however, when the responses of
transferred splenocytes were tested in the absence of replenish-
ment of naive B cells from the bone marrow, the IgG levels
rapidly fell below the level of detection (Fig. 5). This finding
reveals a more profound defect of antiviral antibody responses,
which may be masked in persistently PyV-infected mice by
continuous activation of newly emerging B cells from the bone
marrow.
In mice CR2 is expressed on B cells and on FDC, and two
hypothetical mechanisms for the enhancement of humoral
immune responses by C3d–CR2 interactions have been
postulated. First, antigen-bound complement may act directly
on B cells by binding to the CD21/CD19/CD81 BCR co-
receptor complex (Carter and Fearon, 1992). In this case,
simultaneous co-ligation of the BCR and CR2 is thought to
deliver a strong positive signal for B cells promoting the
secretion of antibodies. Alternatively, entrapment of antigen–
antibody–complement complexes by CR2 expressed on FDC
may ensure long-term antigen retention thus sustaining
antibody responses. Experimental observations support both
of these models (Carter and Fearon, 1992; Croix et al., 1996;
Fischer et al., 1998; Qin et al., 1998). Our experiments did not
exclude the possibility that CR2 expressed on FDC is playing a
role in the enhancement of TI and TD IgG responses to PyV, but
the adoptive transfer experiments make it likely that CR2
signaling on B cells is mostly responsible for this effect. In
SCID mice reconstituted with CR2 KO spleen cells, the host can
generate FDC (Pihlgren et al., 2003) that express wild-type
CR2, although the B lymphocytes derived from the donor are
CR2-deficient, and these mice show seriously impaired VP1-
specific IgG responses.
Consistent with previous observations, the effect of
complement–CR2 interactions on TD B cell responses may
be, at least partially, caused by survival signals mediated by
CR2 during the germinal center reaction (Chen et al., 2000;
Fischer et al., 1998). This idea is supported by the increased
fraction of annexin-V-positive germinal center B cells under-
going apoptosis in CR2-deficient mice compared to wild-type,
and also by the rapidly declining IgG responses in SCID mice
reconstituted with CR2-deficient splenocytes. Provision of
survival signals is a major way of control in the immune
system. CR2 signaling may function in this manner so that
responses to non-infectious antigens that do not activate the
complement system are not strong and sustained.
We found that TI antibody responses to PyV infection were
also negatively affected in Cr2−/− mice (Fig. 6). Strong signals
delivered to the BCR are thought to be very important in the
induction of TI antibodies. In fact, B cell epitopes on TI type 2
antigens are usually arranged in a highly repetitive manner so
that they can crosslink the BCR, which is presumed to be
critical for the induction of antibody responses in the absence of
T cell help. PyV is TI type 2 antigen by the definition that Xid B
cells do not respond to it in the absence of T cells (Szomolanyi-
Tsuda et al., 2001). Although PyV, similar to other TI type 2
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not entirely account for its ability to induce TI IgG responses.
We have previously reported that virus-like particles assembled
in baculovirus from recombinant VP1 capsid proteins cannot
elicit TI IgG responses, only live PyV can (Szomolanyi-Tsuda
et al., 1998). Thus, other signals induced by the live virus
infection seem to be essential for the generation of isotype-
switched antibody responses in T cell-deficient host. This study
identifies CR2–C3d interaction as one of the innate signals
enhancing TI IgG secretion to live virus infection.
Impaired antibody responses to group B streptococcal
capsular polysaccharide in CR2-deficient mice were reported.
These TI type 2 responses were mainly generated in the
marginal zone area of the spleen, where the marginal sinuses
delivered blood borne pathogens, and where MZ B cells,
dendritic cells, and MZ macrophages were localized. One of the
distinguishing features of the MZ B cells that produce
antibodies to bacterial polysaccharides is their high expression
of CR2. It has been shown that defective complement-mediated
uptake and localization of the capsular bacterial polysaccharides
to the MZ B cells is mainly responsible for the reduced antibody
responses in CR2-deficient mice (Pozdnyakova et al., 2003).
The TI antibody responses to PyV, however, are not generated
predominantly by MZ B cells (Heath Guay, unpublished);
therefore, the same scenario is not envisioned for VP1-specific
TI antibody responses.
In our studies with PyV-infected CR2 KO mice or SCID
mice reconstituted with CR2-deficient spleen cells, we found
decreased IgG responses in the absence of CR2, but the antiviral
IgM responses were not significantly affected, although in some
experiments on average they were slightly lower in mice that
had CR2 deficiency compared to controls. This finding is in
contrast to the report on VSV infection by Ochsenbein et al.
(1999) showing diminished TI IgM responses but normal IgG
responses in C3−/− mice. Thus, the effect of CR2 deficiency
seems to be quite different in various viral models. The factors
that may be influencing the role of CR2-mediated mechanisms
in antiviral antibody responses include the route of infection and
the ability of the virus to replicate, both affecting local antigen
dose. In addition, the starting germline affinity of BCR to viral
B cell epitopes may also have some effect on the CR2
dependence of the B cell responses. Experiments with
transgenic B cells on CR2 KO or wild-type background
transferred into mice immunized with ligands with different
affinities for the transgenic BCR demonstrated that CR2-
mediated signals were more important for survival of B cells in
the splenic follicles when the BCR had low affinity for the
immunogen (Barrington et al., 2001).
CD21 is part of a complex formed with CD19 and CD81.
CD21 has a short intracellular domain and is thought to be
incapable of transducing signals on it own. Thus, when CD21 is
engaged, its ligand signals are transduced by CD19. Mice
deficient in CD19, however, seem to have a more profound
defect in antibody responses than CR2-deficient mice. Whereas
CR2 KO mice have normal serum immunoglobulin levels,
serum IgM is approximately 75%, and serum IgG1 is about
90% reduced in CD19 KO mice (Ahearn et al., 1996; Engel etal., 1995; Molina et al., 1996; Rickert et al., 1995). Moreover,
VSV-infected C3−/−, C4−/−, and Cr2−/− mice have long-
lasting virus-specific neutralizing IgG responses and maintain
high frequencies of antibody-secreting cells in the spleen and
bone marrow, but in CD19 KO mice the antiviral antibody titers
in the serum and the number of antibody-secreting cells greatly
decline with time, these mice have impaired B cell memory
(Fehr et al., 1998; Ochsenbein et al., 1999). These observations
all suggest that CD19 may also function in association with
other receptors and may respond to other ligands that influence
humoral immune responses, in addition to C3d–CD21. In fact,
recently it was reported that CD19 is associated with RP105, a
member of the TLR family expressed on B lymphocytes,
forming the signaling component of the complex. So far, LPS is
the only known ligand that activates the RP105/CD19 pathway.
The unique in vivo model of PyV infection in mice allowed
us to study the effect of innate immune signals on TD and on TI
antiviral IgM and IgG responses. We found that in the absence
of CD21/CD35 in Cr2−/−mice the antiviral IgG responses were
reduced, and in mice lacking newly recruited B cells, these
responses were severely compromised. In addition, TI IgG
responses to PyV generated in the absence of T cells were also
greatly reduced; thus, CR2-mediated pathways can make
important contribution to both TD and TI antiviral humoral
immunity in this mouse model of natural virus infection.
Materials and methods
Mice, virus, infections
B6x129/CR2 KO mice and wild-type control B6X129 mice
were originally obtained from the Center for Blood Research,
Harvard University, Boston, MA. These mice, as well as B6/
SCID mice, were bred and kept until infection in the
Department of Animal Medicine at the UMMS under specific
pathogen-free conditions. For the experiments 8–20 weeks old,
age- and sex-matched groups of mice were used. Mice were
infected intraperitoneally (ip) with 2 × 106 plaque forming units
(pfu) of PyV strain A2, originally provided by Dr. Michelle
Fluck (University of Michigan, Ann Arbor), propagated on NIH
3T3 cells, and quantified by plaque assays on UC1b cells as
described (Staneloni et al., 1977).
Adoptive transfer experiments, in vitro and in vivo T cell
depletion
Adoptive transfer of B cell-containing spleen cell popula-
tions from CR2−/− or wild-type mice into SCID mice was
performed as described previously (Szomolanyi-Tsuda and
Welsh, 1996). Briefly, spleens were homogenized between glass
frosted microscope slides, and the resulting spleen cell
suspensions were treated with 0.83% ammonium chloride to
lyse erythrocytes. The resulting cells were washed and counted.
In some experiments, T cells were depleted by negative
selection on anti-mouse Thy1.2 AutoMacs separator columns
(Miltenyi Biotech, Auburn, CA) following protocols given by
the manufacturer. Aliquots of the cell suspensions were stained
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by FACS to determine the completeness of T cell depletion and
the percentage of B cells. Forty million spleen cells of either
wild-type or CR2 KO mice were given intravenously to SCID
mice by tail vein injection, and the mice were infected 1 day
later intraperitoneally with PyV. In the experiments transferring
T cell-depleted spleen cells, 2–3 × 107 cells per mouse were
given. CD4+ cells were depleted in vivo by ip injection with 0.5
mg GK1.5 monoclonal antibody given 1 day before and on days
9 and 14 post-infection. The depletion was confirmed by FACS
analysis.
VP1-specific ELISA assays
Recombinant VP1 capsid protein (50 ng/well) that was
produced in Escherichia coli (Leavitt et al., 1985) was used to
coat 96-well plates, and the VP1-specific ELISA assays were
done as previously described (Szomolanyi-Tsuda et al., 1998).
VP1-specific ELISPOT assays
A modification of the method described for detecting
influenza virus-specific ASC (Guay et al., 2004) was used.
Multiscreen HA plates (Millipore) were coated with 50 ng/well
VP1 overnight at 4 °C and blocked the next day for 30 min at 37
°C with RPMI/10% FBS. Cells were plated in duplicate in 0.2
ml at 1 × 106, 2.5 × 105, 6.25 × 104, and 1.25 × 104 cells/well
and incubated for 4 h at 37 °C. Bound antibody was detected
using 100 μl biotin-conjugated goat antibodies specific for
mouse IgG (Vector Laboratories) and Streptavidin-conjugated
HRP (Vector Laboratories). Plates were developed with AEC
substrate (Sigma) according to the manufacturer's protocol.
Spots were counted using a dissection microscope.
FACS staining
Staining of spleen cell populations and FACS analysis was
performed following standard protocols. Anti-CD4-FITC and
anti-CD8-PE (BD Pharmingen) were used to test the efficiency
of T cell depletions. The CD19, GL7, and annexin V-specific
antibodies were all purchased from BD Pharmingen.
Real-time PCR assays to measure viral DNA in organs
Real-time PCR assay quantifying PyVA2 VP1 coding region
and mouse genomic β actin sequence-specific DNAwas used to
measure virus load. The DNA samples used in the real-time
PCR assays were prepared from mouse organs as previously
described (Szomolanyi-Tsuda andWelsh, 1996) and predigested
with BamHI for 1 h at 37 °C to fragment the cellular DNA.
BamHI cuts the PyV genome once, linearizing it. PCR
amplification was carried out in 50-μl reactions consisting of
50 mM Tris pH 8.0, 0.5 μg/ml BSA, 3 mMMgCl2, 0.25 mM of
each deoxynucleoside triphosphate, 0.5 U of Promega Taq
Polymerase, 0.66 U SYBR-Green I (Molecular Probes), 0.1 mM
forward primer, 0.1 mM reverse primer (Invitrogen, Carlsbad,
CA), 5 nM Fluorescein (Bio-Rad, Hercules, CA), and 1 μg ofappropriate DNA sample. The following primers were used: β
actin forward primer: CGA GGC CCA GAG CAA GAG AG; β
actin reverse primer: CGG TTG GCC TTA GGG TTC AG; PyV
forward primer: CCC CCG GTA CAG GTT TCA GTC CCA
TCAT; PyV reverse primer: GGC ACA ACA GCT CCA CCC
GTC CTG CAG. PCR amplification using the PyV primers was
carried out starting with one cycle at 95 °C for 3 min, 37 cycles
of 95 °C for 30 s, 65 °C for 20 s, 72 °C for 45 s, with a
measurement of fluorescence taken at 72 °C at the end of each
cycle. A melting curve was generated after the completion of the
37 cycles. PCR amplification using the β actin primers was
performed, starting with one cycle at 95 °C for 150 s, followed
by 40 cycles of 95 °C for 30 s, 62 °C for 25 s, 72 °C for 25 s with
a measurement of fluorescence taken at 72 °C at the end of each
cycle, a melting curve was then established as described above
for the PyV amplification. Negative controls included reaction
with no DNA substrate, for the PyV amplification also DNA
from uninfected mouse tissues. Twofold serial dilutions from 1
μg mouse DNA to 31 ng (from uninfected mouse) were used to
generate a standard curve for the β actin amplifications. To
determine PyV copy numbers, we used a recombinant plasmid
containing PyV VP1 coding sequences in serial dilutions from
2 × 108 copies to 20 copies, and we mixed each of these standard
plasmid dilutions with 1 μg of DNA from uninfected mouse
tissues. All samples were run in duplicates. The obtained PyV
copy number data were normalized for the amount of genomic
DNA substrate in the reaction determined by the β actin gene-
specific reaction. The results were first expressed as PyV copies/
μg DNA. This value was then converted to PyV copies/cell.
Assuming the DNA content of 2 × 105 mammalian cells to be 1
μg DNA, 100 copies of PyV/μg DNA (the approximate limit of
detection) are equivalent to 0.0005 copy/cell or 1 copy of PyV
genome in 2000 cells. The data were used for analysis only if the
melting curve of the amplification product was characteristic for
the PyV fragment (or the β actin sequence when β actin-specific
primers were used).
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